Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER-2 Gene Amplification × Capecitabine × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Rectal Neoplasms 8 Adenocarcinoma Of Esophagus 6 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Adenocarcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neoplasms 4 Neoplasm Metastasis 4 Pancreatic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Anus Neoplasms 2 Spinocerebellar Degenerations 1 Somatostatinoma 1 Rectal Cancer Patients 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Locally Advanced Rectal Cancer 1 Locally Advanced Colorectal Cancer 1 HR+HER2- Breast Cancer 1 HIV Infections 1 HER2-positive Gastric Cancer 1 HER2-positive Breast Cancer 1 HER 2 Positive Gastric Cancer 1 Elderly Metastatic Colorectal Cancer Patients 1 Colonic Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡